Search results
PROMOTED
Start date:
Jun 10, 2026
Transcatheter edge-to-edge repair (TEER) is rapidly emerging as an important treatment option for patients with tricuspid regurgitation. Successful procedures require a detailed understanding of tricuspid valve anatomy, precise imaging guidance, and thoughtful procedural planning—especially in complex anatomies.This webinar brings together leading experts Prof Andrew Cook (UCL Institute…
View more
PROMOTED
Start date:
Jan 21, 2026
Pacemaker implantation remains one of the most common complications after TAVI. In this webinar, chaired by Prof Rafal Dworakowski (Abbott APAC Medical Affairs Director, Singapore, SG) and Dr Simon Lam (Queen Mary Hospital, Hong Kong, HK), leading specialists will focus on the anatomy of the conduction system anatomy, highlight key pre-procedural planning considerations, and share proven…
View more
Added:
1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in…
View more
Added:
8 months ago
Source:
Transcatheter Academy
The long-term durability of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease has been a subject of recent debate. New 3-year follow-up data from the Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE) trial show that the clinical benefits of a physiology-guided complete revascularization strategy are sustained over time…
View more
Added:
2 weeks ago
EuroPCR 2026 – Dr Brian Bergmark (Brigham and Women's Hospital, Boston, MA, US) joins us to discuss findings from the VESALIUS-CV trial, examining the effect of evolocumab in patients who have undergone coronary stenting but have no prior myocardial infarction or stroke.VESALIUS-CV is a double-blind, randomised, placebo-controlled, multicentre phase 3 trial enrolling 12,301 high-cardiovascular…
View more
Added:
1 year ago
SCAI 2025 - Outcomes from prosthesis-patient mismatch (PPM) in patients undergoing transcatheter aortic valve implantation (TAVI) show higher rates of severe predicted and measured PPM in female patients compared to male patients; however, PPM did not affect the five-year survival in women.Dr Karim Al-Azizi (Baylor Scott & White The Heart Hospital, Plano, US) joins us to discuss the incidence and…
View more
Added:
5 months ago
Navigate the critical decision-making process for transcatheter mitral valve replacement with Dr Alison Duncan (Royal Brompton & Harefield Hospitals, London, UK).This presentation, part of the comprehensive Complex Cases track in interventional cardiology, addresses the fundamental question of patient selection: which anatomies are unsuitable for TEER and therefore candidates for TMVR? Dr Duncan…
View more
TSP in Patients with ASO
Added:
6 months ago
Review Article
Added:
1 year ago
Added:
9 months ago
The ESC Congress 2025 symposium, “Transforming the Care of Female and Low-Risk Younger Patients With Aortic Stenosis Through Guidelines” is now available on demand.Chaired by Prof Stephan Windecker (Bern University Hospital, Bern, Switzerland) and Prof Vijay Kunadian (Newcastle University, Newcastle-upon-Tyne, UK), this session explores evolving strategies to optimise care for women and younger…
View more